Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of Kerra Formula Capsule in healthy volunteers
TCTR20230320009Phase 1Completed
- Sponsor
- Eastern Herb Company
- Start
- Nov 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, single-arm trial of Kerra, sponsored by Eastern Herb Company. Primary endpoint: Safety and tolerability. Started Nov 2022; status: completed.
02
Drugs
Kerra
Beyond the preview
Go deeper on TCTR20230320009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230320009.